NCT06502431View on ClinicalTrials.gov

Analysis of Disturbances in Neurofluid Dynamics in Type I Chiari Malformations

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

July 31, 2027

Conditions
Type I Chiari MalformationCerebral HemodynamicCraniospinal HydrodynamicPhase Contrast MRICerebrospinal Fluid
Interventions
OTHER

phase contrast sequences

patients will benefit from phase contrast sequences complementary to the morphological MRI performed as part of the patient management.

Trial Locations (1)

80054

CHU Amiens Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT06502431 - Analysis of Disturbances in Neurofluid Dynamics in Type I Chiari Malformations | Biotech Hunter | Biotech Hunter